GALT icon

Galectin Therapeutics

59 hedge funds and large institutions have $18.2M invested in Galectin Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 11 closing their positions.

Holders
59
Holders Change
-7
Holders Change %
-10.61%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
17
Reduced
10
Closed
11
Calls
$154K
Puts
$16K
Net Calls
+$138K
Net Calls Change
+$116K
Name Market Value Shares Shares
Change
Shares
Change %
BC
51
Barrett & Company
Rhode Island
$9.16K 3,834
MAM
52
Meeder Asset Management
Ohio
$9.12K 3,817
SIS
53
Sound Income Strategies
Florida
$7.12K 2,980
JPMorgan Chase & Co
54
JPMorgan Chase & Co
New York
$4.47K 1,871 +48 +3%
BFEC
55
Benjamin F. Edwards & Company
Missouri
$4K 1,775
BCPWM
56
Bradley & Co Private Wealth Management
Florida
$2.39K 1,000
Group One Trading
57
Group One Trading
Illinois
$1.3K 542 +542 New
GRP
58
Global Retirement Partners
California
$598 250
SIC
59
Salem Investment Counselors
North Carolina
$400 167
6CM
60
683 Capital Management
New York
-111,035 Closed
MML Investors Services
61
MML Investors Services
Massachusetts
-54,227 Closed
IAA
62
Independent Advisor Alliance
North Carolina
-36,100 Closed
AWM
63
AE Wealth Management
Kansas
-26,841 Closed
BFM
64
Boothbay Fund Management
New York
-23,749 Closed
Bank of New York Mellon
65
Bank of New York Mellon
New York
-23,080 Closed
Citigroup
66
Citigroup
New York
-10,650 Closed
GI
67
Gradient Investments
Minnesota
-3,800 Closed
IA
68
IFP Advisors
Florida
-2,000 Closed
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
-1,069 Closed
UBS Group
70
UBS Group
Switzerland
-622 Closed
Wolverine Trading
71
Wolverine Trading
Illinois
BWL
72
Bogart Wealth LLC
Virginia
CFGS
73
Concourse Financial Group Securities
Alabama